News from Europe/Pharnext/Vitamin C

[Guest guest]

News from Europe

(this is just a bit of news from my CMT friends in Europe)

The Pharnext-project is a totally funded private venture capital and biotech

research project. They'll be using different molecules in the two year CMT study

on the use of Pleodrugs. It will start in 2011 and last for 2 years. In April

there will be a congress in Nantes and Prof. Cohen will be there. The French CMT

people hope that he will give more information.

The French Vitamin C study ended with the following " results " : 3gr Vit. C showed

light improvement for the patients but couldn't be seen by the doctors. In

France where 180 people participated in the old study, some of them feel better

taking 3gr Vitamin C although there is no official result. CMT France now waits

for the American results with 4gr but this study will will not conclude until

March 2011.

The Italian Vitamin study only used 1.5gr and results have not been published.